NCT02338518 2023-09-29
SVOSA
Jinling Hospital, China
Phase 3 Unknown
Clinical Trials
6 trialsNCT02177552 2019-02-15
SEED
Rigshospitalet, Denmark
Phase 2 Unknown
NCT03668418 2018-09-12
xenoZ
University of Pisa
Unknown
NCT02949258 2016-10-31
NCT-B4
Jinling Hospital, China
Phase 2 Unknown
NCT01964027 2013-10-17
SIEG
Anhui Medical University
Phase 2 Unknown
NCT00075465 2008-07-24
Docetaxel and Epirubicin as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Adenocarcinoma of the Stomach
National Cancer Institute (NCI)
Phase 2 Unknown